Medical software solutions
The company develops medical apps and software solutions for pharmaceutical, medtech, life science, and health insurance sectors.
Source: LinkedIn company description · Retrieved November 17, 2026

BAYOOMED is part of the BAYOONET Group and develops medical apps and software solutions.
The company develops regulated medical software in Europe and reports over 13 years of experience in medical software development. It offers clients collaboration opportunities spanning the process chain from concept development to market launch.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Its clients are in the pharmaceutical, medtech, life science, and health insurance sectors.
The company develops medical apps and software solutions for pharmaceutical, medtech, life science, and health insurance sectors.
Source: LinkedIn company description · Retrieved November 17, 2026
Its expertise includes Digital Health Applications, Digital Therapeutics, AI-driven solutions, and cybersecurity for connected medical devices.
Source: LinkedIn company description · Retrieved November 17, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on November 17, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 18, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 28, 2026, September 29, 2026, November 5, 2026 and November 6, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.